ExodusPoint Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-300,000
Closed -$6.86M 1953
2022
Q1
$6.86M Buy
300,000
+225,000
+300% +$5.5M 0.09% 293
2021
Q4
$2.07M Sell
75,000
-75,000
-50% -$2.01M 0.02% 746
2021
Q3
$4.18M Sell
150,000
-50,000
-25% -$1.42M 0.06% 463
2021
Q2
$5.87M Buy
200,000
+50,000
+33% +$1.51M 0.06% 301
2021
Q1
$4.76M Buy
150,000
+107,500
+253% +$3.15M 0.07% 291
2020
Q4
$884K Buy
+42,500
New +$793K 0.01% 923
2020
Q3
Sell
-200,000
Closed -$3.56M 1753
2020
Q2
$3.56M Buy
+200,000
New +$3.52M 0.09% 241

Other funds holding BHC

ExodusPoint Capital Management's BHC Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Bausch Health (BHC) in Q3 2025, closing a stake of 142,000 shares — an estimated $946K sold.

ExodusPoint Capital Management first reported a position in BHC in Q4 2018 and held it in 17 quarters. The position peaked at $19.9M in Q3 2021. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.

  • ExodusPoint Capital Management reported no remaining Bausch Health position as of Q3 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 142,000 Bausch Health shares in Q3 2025, an estimated $946K.
  • ExodusPoint Capital Management first reported a position in Bausch Health in Q4 2018 and held it in 17 quarters.
  • ExodusPoint Capital Management's Bausch Health position peaked at $19.9M in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.